Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$693M |
| 2 |
Constellation Brands
STZ
|
+$368M |
| 3 |
Tesla
TSLA
|
+$332M |
| 4 |
NVIDIA
NVDA
|
+$300M |
| 5 |
Booking.com
BKNG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$821M |
| 2 |
Netflix
NFLX
|
+$777M |
| 3 |
AbbVie
ABBV
|
+$583M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$477M |
| 5 |
FedEx
FDX
|
+$456M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Consumer Discretionary | 17.72% |
| 3 | Financials | 13.25% |
| 4 | Healthcare | 11.94% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPBI
551
DELISTED
Pacific Premier Bancorp
PPBI
| $1.32M | ﹤0.01% |
34,612
+12,839
| +59% | +$524K |
|
|
CHS
552
DELISTED
Chicos FAS, Inc.
CHS
| $1.3M | ﹤0.01% |
159,940
+56,501
| +55% | +$535K |
|
553
TransUnion
TRU
$16.5B
| $1.29M | ﹤0.01% |
+18,076
| New | +$1.2M |
|
554
The Greenbrier Companies
GBX
$1.58B
| $1.23M | ﹤0.01% |
+23,326
| New | +$1.11M |
|
|
SAFM
555
DELISTED
Sanderson Farms Inc
SAFM
| $1.2M | ﹤0.01% |
11,431
+367
| +3% | +$39.8K |
|
556
Bloomin' Brands
BLMN
$743M
| $1.2M | ﹤0.01% |
59,634
+8,083
| +16% | +$184K |
|
|
NAVG
557
DELISTED
Navigators Group Inc
NAVG
| $1.18M | ﹤0.01% |
20,653
-3,158
| -13% | -$184K |
|
|
FDC
558
DELISTED
First Data Corporation
FDC
| $1.15M | ﹤0.01% |
+54,883
| New | +$1.02M |
|
|
TEN
559
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $1.14M | ﹤0.01% |
25,906
-9,909
| -28% | -$477K |
|
560
Sociedad Química y Minera de Chile
SQM
$19.2B
| $1.13M | ﹤0.01% |
23,546
+138
| +0.6% | +$7.24K |
|
561
OceanFirst Financial
OCFC
$1.73B
| $1.12M | ﹤0.01% |
37,293
-19,044
| -34% | -$538K |
|
562
Moog Inc Class A
MOG.A
$13.4B
| $1.08M | ﹤0.01% |
13,909
-471
| -3% | -$38.8K |
|
|
HF
563
DELISTED
HFF Inc.
HF
| $1.07M | ﹤0.01% |
31,153
-6,473
| -17% | -$247K |
|
564
Myriad Genetics
MYGN
$506M
| $1.07M | ﹤0.01% |
28,604
+613
| +2% | +$20.7K |
|
565
CME Group
CME
$93.7B
| $1.06M | ﹤0.01% |
+6,454
| New | +$1.05M |
|
|
PSDO
566
DELISTED
Presidio, Inc. Common Stock
PSDO
| $1.05M | ﹤0.01% |
80,067
-527,908
| -87% | -$7.69M |
|
567
Deckers Outdoor
DECK
$14B
| $986K | ﹤0.01% |
52,404
+30,228
| +136% | +$523K |
|
568
Intuit
INTU
$86.4B
| $985K | ﹤0.01% |
4,822
+3,154
| +189% | +$605K |
|
569
PagSeguro Digital
PAGS
$2.66B
| $971K | ﹤0.01% |
34,979
-391,698
| -92% | -$12.9M |
|
|
NAK
570
Northern Dynasty Minerals
NAK
$818M
| $955K | ﹤0.01% |
1,763,422
| – | – |
|
571
Artisan Partners
APAM
$2.96B
| $891K | ﹤0.01% |
29,562
-1,053
| -3% | -$34.2K |
|
572
Synchrony
SYF
$25B
| $887K | ﹤0.01% |
+26,577
| New | +$913K |
|
|
CLDT
573
Chatham Lodging
CLDT
$630M
| $873K | ﹤0.01% |
41,138
-1,326,352
| -97% | -$26.4M |
|
574
Acadia Realty Trust
AKR
$2.97B
| $864K | ﹤0.01% |
31,573
-1,152
| -4% | -$28.9K |
|
575
Globus Medical
GMED
$10.9B
| $853K | ﹤0.01% |
16,899
-5,432
| -24% | -$283K |
|
Similar funds
Jennison Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Jennison Associates held 740 positions worth $103B, up 2% from $101B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Jennison Associates withdrew a net $3.95B in Q2 2018, closing 87 positions and reducing 296 holdings. Its most notable exit was Great Plains Energy Incorporated, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in AstraZeneca worth $677M.
- Jennison Associates's largest Q2 2018 buy was AstraZeneca: 9,637,084 shares worth $677M.
- Jennison Associates added most to Constellation Brands in Q2 2018, an estimated $368M increase.
- Jennison Associates's biggest Q2 2018 reduction was Charter Communications, cutting an estimated $821M.
- Jennison Associates fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $152M.
- Jennison Associates's ten largest holdings make up 29% of its $103B portfolio in Q2 2018.
- Jennison Associates opened 89 new positions and closed 87 in Q2 2018.
- Jennison Associates's portfolio value rose 2% quarter-over-quarter to $103B.
Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.